BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vegting Y, Vogt L, Anders HJ, de Winther MPJ, Bemelman FJ, Hilhorst ML. Monocytes and macrophages in ANCA-associated vasculitis. Autoimmun Rev 2021;20:102911. [PMID: 34298153 DOI: 10.1016/j.autrev.2021.102911] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Nishide M, Nishimura K, Matsushita H, Edahiro R, Inukai S, Shimagami H, Kawada S, Kato Y, Kawasaki T, Tsujimoto K, Kamon H, Omiya R, Okada Y, Hattori K, Narazaki M, Kumanogoh A. Single-cell multi-omics analysis identifies two distinct phenotypes of newly-onset microscopic polyangiitis.. [DOI: 10.21203/rs.3.rs-2466890/v1] [Reference Citation Analysis]
2 Matsumoto K, Suzuki K, Yasuoka H, Hirahashi J, Yoshida H, Magi M, Noguchi-Sasaki M, Kaneko Y, Takeuchi T. Longitudinal monitoring of circulating immune cell phenotypes in anti-neutrophil cytoplasmic antibody-associated vasculitis. Autoimmun Rev 2023;22:103271. [PMID: 36627064 DOI: 10.1016/j.autrev.2023.103271] [Reference Citation Analysis]
3 Sotero D, Benvindo-souza M, Lopes AC, de Freitas RP, Silva DME. Impacts of nickel mining on the DNA and hematological parameters of two species of bat in central Brazil.. [DOI: 10.21203/rs.3.rs-2367486/v1] [Reference Citation Analysis]
4 Scurt FG, Bose K, Hammoud B, Brandt S, Bernhardt A, Gross C, Mertens PR, Chatzikyrkou C. Old known and possible new biomarkers of ANCA-associated vasculitis. J Autoimmun 2022;133:102953. [PMID: 36410262 DOI: 10.1016/j.jaut.2022.102953] [Reference Citation Analysis]
5 Kwant LE, Vegting Y, Tsang-A-Sjoe MWP, Kwakernaak AJ, Vogt L, Voskuyl AE, van Vollenhoven RF, de Winther MPJ, Bemelman FJ, Anders HJ, Hilhorst ML. Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue. Autoimmun Rev 2022;21:103211. [PMID: 36252930 DOI: 10.1016/j.autrev.2022.103211] [Reference Citation Analysis]
6 An X, Wei Z, Xie Y, Xu J, Shen Y, Ni L, Shi H, Shen P, Zhang W, Chen Y. CD206+CD68+ mono-macrophages and serum soluble CD206 level are increased in antineutrophil cytoplasmic antibodies associated glomerulonephritis. BMC Immunol 2022;23:55. [DOI: 10.1186/s12865-022-00529-w] [Reference Citation Analysis]
7 Zhou X, Chen Q, Guo C, Su Y, Guo H, Cao M, Liu Z, Zhang D, Diao N, Fan H, Chen D. CD44 Receptor-Targeted and Reactive Oxygen Species-Responsive H2S Donor Micelles Based on Hyaluronic Acid for the Therapy of Renal Ischemia/Reperfusion Injury. ACS Omega 2022. [DOI: 10.1021/acsomega.2c05407] [Reference Citation Analysis]
8 Xu L, Kant S, Aqeel F, Antiochos B, Li C, Snopkowski C, Seo P, Gapud EJ, Muthukumar T, Geetha D. Urinary cell mRNA profiling distinguishes disease activity in antineutrophil cytoplasmic antibody-associated glomerulonephritis. J Nephrol 2022. [PMID: 36083534 DOI: 10.1007/s40620-022-01460-4] [Reference Citation Analysis]
9 Tang J, Liao Z, Luo L, Deng S, Jiang Y, Wang F, Hu X, Yin H, Gong G, Feng J, Li X. CX3CL1-induced CD16+ monocytes extravasation in myeloperoxidase-ANCA-associated vasculitis correlates with renal damage. Front Immunol 2022;13:929244. [DOI: 10.3389/fimmu.2022.929244] [Reference Citation Analysis]
10 Watanabe R, Hashimoto M. Pathogenic role of monocytes/macrophages in large vessel vasculitis. Front Immunol 2022;13:859502. [DOI: 10.3389/fimmu.2022.859502] [Reference Citation Analysis]
11 Al-soudi A, Vegting Y, Klarenbeek PL, Hilhorst ML. Do Relapses Follow ANCA Rises? A Systematic Review and Meta-Analysis on the Value of Serial ANCA Level Evaluation. Front Med 2022;9:844112. [DOI: 10.3389/fmed.2022.844112] [Reference Citation Analysis]
12 Molnár A, Studinger P, Ledó N. Diagnostic and Therapeutic Approach in ANCA-Associated Glomerulonephritis: A Review on Management Strategies. Front Med 2022;9:884188. [DOI: 10.3389/fmed.2022.884188] [Reference Citation Analysis]
13 Wang T, Liu G, Guo X, Ji W, Xu Y. Single-Cell Analysis Reveals the Role of the Neuropeptide Receptor FPR2 in Monocytes in Kawasaki Disease: A Bioinformatic Study. Disease Markers 2022;2022:1-15. [DOI: 10.1155/2022/1666240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Massicotte-azarniouch D, Herrera CA, Jennette JC, Falk RJ, Free ME. Mechanisms of vascular damage in ANCA vasculitis. Semin Immunopathol. [DOI: 10.1007/s00281-022-00920-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Xia MD, Yu RR, Chen DM. Identification of Hub Biomarkers and Immune-Related Pathways Participating in the Progression of Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis. Front Immunol 2021;12:809325. [PMID: 35069594 DOI: 10.3389/fimmu.2021.809325] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Mukherjee M, Nair P. Eosinophils as potential mediators of autoimmunity in eosinophilic lung disease. Eosinophilic Lung Diseases 2022. [DOI: 10.1183/2312508x.10030720] [Reference Citation Analysis]
17 Sciascia S, Ponticelli C, Roccatello D. Pathogenesis-based new perspectives of management of ANCA-associated vasculitis. Autoimmun Rev 2021;:103030. [PMID: 34971805 DOI: 10.1016/j.autrev.2021.103030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Bošnjak M, Večerić-haler Ž, Boštjančič E, Kojc N. Renal Tissue miRNA Expression Profiles in ANCA-Associated Vasculitis—A Comparative Analysis. IJMS 2021;23:105. [DOI: 10.3390/ijms23010105] [Reference Citation Analysis]
19 Padoan R, Campaniello D, Gatto M, Schiavon F, Doria A. Current clinical and therapeutic approach to tumour-like mass lesions in granulomatosis with polyangiitis. Autoimmun Rev 2021;21:103018. [PMID: 34902605 DOI: 10.1016/j.autrev.2021.103018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 de Cos M, Xipell M, García-Herrera A, Lledo GM, Guillen E, Blasco M, Espinosa G, Cervera R, Quintana LF. Assessing and counteracting fibrosis is a cornerstone of the treatment of CKD secondary to systemic and renal limited autoimmune disorders. Autoimmun Rev 2021;21:103014. [PMID: 34896651 DOI: 10.1016/j.autrev.2021.103014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Sepe V, Libetta C, Gregorini M, Rampino T. The innate immune system in human kidney inflammaging. J Nephrol 2021. [PMID: 34826123 DOI: 10.1007/s40620-021-01153-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 de Groot EL, Ossewaarde-van Norel J, Hoefer IE, Haitjema S, de Boer JH, Kuiper JJW. Central Multifocal Choroiditis: Platelet Granularity as a Potential Marker for Treatment With Steroid-Sparing Immunomodulatory Therapy. Front Ophthalmol 2021;1. [DOI: 10.3389/fopht.2021.784848] [Reference Citation Analysis]
23 Hilhorst M, Anders HJ. IgA Nephropathy Needs a Diagnostic Marker of Immunologic Activity to Select the Right Patients for Immunotherapies. J Am Soc Nephrol 2021:ASN. [PMID: 34789549 DOI: 10.1681/ASN.2021091239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]